Pubic osteomyelitis: Epidemiology and factors associated with treatment failure.


Journal

Medecine et maladies infectieuses
ISSN: 1769-6690
Titre abrégé: Med Mal Infect
Pays: France
ID NLM: 0311416

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 06 10 2018
revised: 09 12 2018
accepted: 21 10 2019
pubmed: 23 11 2019
medline: 29 10 2021
entrez: 23 11 2019
Statut: ppublish

Résumé

To describe the epidemiology of pubic osteomyelitis (PO) and to look for factors associated with treatment failure. Retrospective study describing PO according to outcome: success or failure of initial management. Factors associated with failure determined by univariate Cox analysis. Kaplan-Meier curve compared between groups by log-rank test. Twenty-five patients were included over a 13-year period; 24% of PO had blood-borne infection. Failure (44%) was always observed in chronic postoperative presentations (76%). Fistula (32%) was only observed in postoperative presentations and was significantly associated with failure (HR 5.1; P=0.011). Other risk factors were pelvic malignant tumor history, abscess, infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae, and polymicrobial infection. PO is most often a chronic postoperative polymicrobial infection in patients with comorbidities at high risk of relapse. Studies in larger cohorts could assess the efficacy of more aggressive surgical strategies in patients at high risk of failure.

Identifiants

pubmed: 31753589
pii: S0399-077X(19)31064-9
doi: 10.1016/j.medmal.2019.10.012
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

684-688

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

A Becker (A)

Service des maladies infectieuses et tropicales, CRIOAc Lyon, hospices civils de Lyon, 69004 Lyon, France. Electronic address: agathe.becker01@chu-lyon.fr.

C Triffault-Fillit (C)

Service des maladies infectieuses et tropicales, CRIOAc Lyon, hospices civils de Lyon, 69004 Lyon, France.

F Valour (F)

Service des maladies infectieuses et tropicales, CRIOAc Lyon, hospices civils de Lyon, 69004 Lyon, France; Inserm U1111, centre international de recherche en infectiologie (CIRI), université Claude-Bernard Lyon 1, 69008 Lyon, France.

L Boussel (L)

Service de radiologie, hôpital de la Croix Rousse, hospices civils de Lyon, 69004 Lyon, France.

A Ruffion (A)

Service d'urologie, centre hospitalier Lyon Sud, hospices civils de Lyon, 69310 Lyon, France.

F Laurent (F)

Institut des agents infectieux, laboratoire de bactériologie, hospices civils de Lyon, 69004 Lyon, France.

E Senneville (E)

Service universitaire des maladies infectieuses et tropicales, centre hospitalier Gustave-Dron, 59200 Tourcoing, France.

C Chidiac (C)

Service des maladies infectieuses et tropicales, CRIOAc Lyon, hospices civils de Lyon, 69004 Lyon, France.

T Ferry (T)

Service des maladies infectieuses et tropicales, CRIOAc Lyon, hospices civils de Lyon, 69004 Lyon, France; Inserm U1111, centre international de recherche en infectiologie (CIRI), université Claude-Bernard Lyon 1, 69008 Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH